This draft of the Official Round Table held during the 99th SIO National Congress is an updated review on the diagnostic tools, the importance of polysomnographic recording and a critical analysis of the surgical techniques in obstructive sleep apnoea syndrome (OSAS). The review and analysis of available publications is the premise along with a specific analysis of the relationship between OSAS and metabolic and vascular disorders. In addition, the most recent investigations on sleep disorders and altered glucose metabolism are summarised and discussed together with the results of a study by the authors involving a fairly large number of patients with OSAS and diabetes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035845PMC

Publication Analysis

Top Keywords

osas metabolic
8
round table
8
99th sio
8
sio national
8
national congress
8
osas
4
metabolic diseases
4
diseases round
4
table 99th
4
congress bari
4

Similar Publications

Combined exposure to mixed brominated flame retardants on obstructive sleep apnea syndrome in US adults.

BMC Public Health

January 2025

Department of Social Medicine, School of Health Management, Harbin Medical University, Harbin, 150081, China.

Background: Accumulating research highlights that exposure to serum brominated flame retardants (BFRs) may elevate health risks. The effects of serum BFRs, both alone and in combination, on obstructive sleep apnea syndrome (OSAS) have not been thoroughly studied. Our main goal was to examine the association between individual and mixtures of serum BFRs and OSAS risk.

View Article and Find Full Text PDF

Obstructive sleep apnea syndrome (OSAS) is prevalent among children and is associated with elevated blood pressure (BP), posing a risk for future hypertension and cardiovascular diseases. While the roles of gut microbiota and systemic inflammation in OSAS pathogenesis are recognized in adults and animal models, their impact on pediatric BP remains less understood. This cross-sectional study explored the relationships between polysomnographic parameters, gut microbiota, systemic inflammation, and BP in 60 children with OSAS.

View Article and Find Full Text PDF

Obstructive sleep apnea syndrome (OSAS) in women: A forgotten cardiovascular risk factor.

Maturitas

December 2024

Department of Translational and Precision Medicine, Sapienza-University of Rome, Viale del Policlinico 155, Rome 00161, Italy. Electronic address:

Sleep-disordered breathing is a highly prevalent disorder with negative impact on healthcare systems worldwide. This condition has detrimental effects on cardiovascular health and quality of life, and is frequently associated with a variety of comorbidities, including cardiovascular disease, heart failure, diabetes and atrial fibrillation. Nevertheless, it remains frequently undiagnosed and undertreated, especially in specific populations.

View Article and Find Full Text PDF

Purpose: The aim of the present systematic review was to corroborate existing evidence on how serum25(OH)D levels affect obstructive sleep apnea syndrome (OSAS) severity in the absence of comorbidities.

Methods: From inception to May 2024, PubMed, Scopus, and Embase electronic databases were systematically screened to identify randomized controlled trials (RCTs), quasi-RCTs, prospective, and retrospective studies. A strict search protocol was applied following the application of PROSPERO, under the registration number CRD42023468744.

View Article and Find Full Text PDF

Sevoflurane aggravates cognitive impairment in OSAS mice through tau phosphorylation and mitochondrial dysfunction.

Exp Neurol

February 2025

Department of Anesthesiology, Tianjin Medical University General Hospital, Tianjin Research Institute of Anesthesiology, Tianjin, China. Electronic address:

Article Synopsis
  • The increase in obstructive sleep apnea syndrome (OSAS) is leading to more patients undergoing surgery, raising concerns about the impact of anesthesia on those with OSAS.
  • In a study using wild-type and Tau-knockout mice, the effects of intermittent hypoxia and sevoflurane on tau phosphorylation and cognitive functions were explored, revealing that sevoflurane worsened cognitive deficits in wild-type OSAS mice primarily through tau-related mitochondrial dysfunction.
  • Idebenone treatment was found to reduce mitochondrial issues and cognitive decline in wild-type OSAS mice but did not alter tau phosphorylation levels, indicating different underlying mechanisms for cognitive impairment caused by OSAS and those worsened by sevoflurane.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!